| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7560122 | DUCHESNAY | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
Jan, 2019
(5 years ago) | |
| US6340695 | DUCHESNAY | Rapid onset formulation |
Jun, 2021
(2 years ago) | |
Diclegis is owned by Duchesnay.
Diclegis contains Doxylamine Succinate; Pyridoxine Hydrochloride.
Diclegis has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Diclegis are:
- US7560122
- US6340695
Diclegis was authorised for market use on 08 April, 2013.
Diclegis is available in tablet, delayed release;oral dosage forms.
Diclegis can be used as treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
The generics of Diclegis are possible to be released after 21 June, 2021.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Apr 08, 2016 |
Drugs and Companies using DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE ingredient
Market Authorisation Date: 08 April, 2013
Treatment: Treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management
Dosage: TABLET, DELAYED RELEASE;ORAL
DICLEGIS family patents
